Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06477146 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Milk Thistle Clinical Trial in Pediatric NAFLD

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion dates: Jan 31, 2026 to Jan 31, 2029
    • Site contact updated
    v5
  2. Notable Lead sponsor: Thomas J Sferra, MD to University Hospitals Cleveland Medical Center
    • Start date: Sep 9, 2024 to Dec 19, 2024
    • Site contact updated
    v4
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 31, 2024 to Sep 9, 2024
    • Site details revised
    v3
  4. Notable Primary endpoints revised (3)
    • Eligibility criteria expanded, about 15 words
    v2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Pediatric Fatty Liver disease is a growing problem in the United States and is expected to be the leading cause of Liver Transplantation in Adults in 20 years. Following lifestyle changes such as diet restrictions and exercise may be difficult to consistently maintain. The purpose of this study is to investigate alternative medical therapy with an herbal supplement called Milk Thistle (MT) which may improve fatty liver disease and would be easier to follow than diet and exercise.
Trial Details
NCT Number NCT06477146
Lead Sponsor University Hospitals Cleveland Medical Center
Conditions
(from sponsor)
Non-Alcoholic Fatty Liver Disease (NAFLD)
Related terms Fatty Liver, Non-alcoholic Fatty Liver Disease
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov